StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Kunal Bothra

BUYMax Healthcare Institute Limited

byKunal BothraHorizon: NA (inferred Swing (≤2wk))20 Jul 2026via ET Now

Entry₹1,105Inferred
Target₹1,140
Total upside +3.17% (call closed)
Stop loss₹1,086-1.72% risk
Exit₹1,08621 Jul 2026, 11:10 am
Stop-loss hit-1.72%
Follow Kunal Bothra for new calls(33% target hit, 225 closed calls)Get alertsWatch MAXHEALTH for new buy/sell callsGet alertsSee 46 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Jul 2026
7 supporting1 neutral1 opposing
Supports the BUY call (7)

HDFC Life Share: காலாண்டு வருமானம் உயர்வு! முதலீட்டாளர்கள் கவனிக்க வேண்டியவை

NewsGoogle News·17 Jul · 3d ago

(opens in new tab)

HDFC Life Gross Premium Up 15% to ₹17,168 Crore in Recent Quarter

NewsGoogle News·17 Jul · 3d ago

(opens in new tab)

HDFC Life Share Price: कंपनीच्या उत्पन्नात **15%** वाढ, हाती आले तब्बल **₹17,168 कोटी**

NewsGoogle News·17 Jul · 3d ago

(opens in new tab)

HDFC Life Share: Q1 નફામાં **12%** નો વધારો, ₹611 કરોડ પહોંચ્યો

NewsGoogle News·16 Jul · 5d ago

(opens in new tab)

HDFC Life Q1 FY27 PAT at ₹611 Cr; Solvency Ratio Strong at 185%

NewsGoogle News·15 Jul · 5d ago

(opens in new tab)
Neutral / worth noting (1)

Max Healthcare Institute Limited's subsidiary, Kalinga Hospital Ltd., is involved in ongoing litigation. An interlocutory petition has been filed requesting a stay on a postal ballot notice related to

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·8 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

HDFC Life Falls 1.8% Despite 12% Profit Rise in Q1 FY27

NewsGoogle News·16 Jul · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.